WAYNE, N.J., Oct. 10, 2011 /PRNewswire/ -- MAQUET Cardiovascular, a leading provider of cardiovascular technologies, announced today that it has signed a three-year, dual-source contract with Premier Healthcare Alliance to provide intra-aortic balloon pumps (IABP) to the Premier membership. The contract includes the CS300 product line, as well as the MEGA™ 8Fr. 50cc IABP Catheter, SENSATION® 7Fr. IABP Catheter and LINEAR™ 7.5Fr. IABP Catheter, which are used in the treatment of cardiogenic shock, acute heart failure, irregular heart rhythms, cardiac surgery, and percutaneous coronary intervention. This contract represents the seventh such contract with Premier covering a wide range of MAQUET Cardiovascular's product lines.
"We are excited to expand existing – and solidify new – agreements with Premier Healthcare Alliance to grow our business," said Raoul Quintero, President of MAQUET Cardiovascular US Sales. "We see these agreements as a critical part of our business, with GPOs contributing nearly 70 percent of our current revenue. We remain fully committed to building these valuable partnerships to strengthen in-hospital presence of our cardiovascular products."
About MAQUET IABP
MAQUET is the global leader in intra-aortic balloon pump (IABP) counterpulsation therapy. The company's continuing dedication to meeting the needs of interventionalists and cardiac surgeons through its ongoing program of research and development in IABP consoles, IAB catheters and related accessories have produced the most advanced technology offering known today. This, combined with the company's never ending commitment to clinical education, make MAQUET the gold standard for patients requiring mechanical cardiac assist. To learn more please visit MAQUET's website, http://ca.maquet.com/
About the Premier healthcare alliance, Malcolm Baldrige National